Kellman Pharmaceutical Services (KPS) has entered a strategic alliance with Y-Prime, a provider of clinical trial management services and software. The two companies will collaborate to develop clinical e-MVR tools, which will be introduced later this year.

“Our new suite of web integrated clinical reporting tools, incorporates decades of trial monitoring experience and metrics that KPS uses for monitoring visit reporting,” said Y-Prime chief executive Shawn Blackburn. “We’re building their best practices into a suite of tools that they will be able to offer their clients for centralized management across a number of studies as a competitive advantage and will leverage their expertise for our own product offerings as well.”

“We’re extremely excited about this collaboration and have worked closely with the Y-Prime team over in recent months leading up to this announcement,” said KPS chief executive officer David Kelly. “Their products are used by major pharma companies worldwide and it’s a great validation of our distinct capabilities that they’ve selected us as a partner.”